Determinants of primary nonadherence in asthma-controller and dyslipidemia pharmacotherapy

American Journal of Pharmacy Benefits

Volumn 2, Issue 2, 2010, Pages 111-118

  Liberman, Joshua N ^a   Hutchins, David S ^a   Popiel, Richard G ^b   Patel, Mihir H ^b   Jan, Saira A ^b   Berger, Jan E ^a  

^a CVS Caremark   (United States)

^b HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS AFFECTING LIPID METABOLISM; ANTIASTHMATIC AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CONTROLLED STUDY; ELECTRONIC PRESCRIBING; FEMALE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH INSURANCE; HOSPITAL PHARMACY; HUMAN; INFANT; MALE; MEDICATION ERROR; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRESCRIPTION; SCHOOL CHILD; TREATMENT REFUSAL;

EID: 77954713708     PISSN: 19454481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497.
2. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36(9):1331-1336.
3. Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm. 2001;58(12):1126-1132.
4. Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations: should we target patients with the most to gain? J Gen Intern Med. 2004;19(6):638-645.
5. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review [published correction appears in JAMA. 2003;289(24):3242]. JAMA. 2002;288(22):2868-2879
6. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60(7):657-665.
7. Rau JL. Determinants of patient adherence to an aerosol regimen. Respir Care. 2005;50(10):1346-1356.
8. Schedlbauer A, Schroeder K, Peters TJ, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev. 2004;(4):CD004371.
9. Schultz JS, O'Donnell JC, McDonough KL, Sasane R, Meyer J. Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population. Am J Manag Care. 2005;11(5):306-312.
10. Takiya LN, Peterson AM, Finley RS. Meta-analysis of interventions for medication adherence to antihypertensives. Ann Pharma-cother. 2004;38(10):1617-1624.
11. Vermeire E, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lindenmeyer A. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;(2):CD003638.
12. Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. Br Med J. 1993;307(6908):846-848.
13. Ekedahl A, Månsson N. Unclaimed prescriptions after automated prescription transmittals to pharmacies. Pharm World Sci. 2004;26(1):26-31.
14. Watts RW, McLennan G, Bassham I, el-Saadi O. Do patients with asthma fill their prescriptions? A primary compliance study. Aust Fam Physician. 1997;26(suppl 1):S4-S6.
15. Williams LK, Joseph CL, Peterson EL, et al. Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol. 2007;120(5):1153-1159.
16. Wroth TH, Pathman DE. Primary medication adherence in a rural population: the role of the patient-physician relationship and satisfaction with care. J Am Board Fam Med. 2006;19(5):478-486.
17. Bell DS, Marken RS, Meili RC, Wang J, Rosen M, Brook RH; RAND Electronic Prescribing Expert Advisory Panel. Recommendations for comparing electronic prescribing systems: results of an expert consensus process. Health Aff (Millwood). 2004;Suppl Web Exclusives:W4-305-17.
18. Ginde AA, Von Harz BC, Turnbow D, Lewis LM. The effect of ED prescription dispensing on patient compliance. Am J Emerg Med. 2003:21(4):313-315.
19. Jones I, Britten N. Why do some patients not cash their prescriptions? Br J Gen Pract. 1998;48(426):903-905.
20. Matsui D, Joubert GI, Dykxhoorn S, Rieder MJ. Compliance with prescription filling in the pediatric emergency department. Arch Pediatr Adolesc Med. 2000;154(2):195-198.
21. Saunders CE. Patient compliance in filling prescriptions after discharge from the emergency department. Am J Emerg Med. 1987;5(4):283-286.
22. Kajioka EH, Itoman EM, Li ML, Taira DA, Li GG, Yamamoto LG. Pediatric prescription pick-up rates after ED visits. Am J Emerg Med. 2005;23(4):454-458.
23. Butler K, Cooper WO. Adherence of pediatric asthma patients with oral corticosteroid prescriptions following pediatric emergency department visit or hospitalization. Pediatr Emerg Care. 2004;20(11):730-735.
24. Thomas EJ, Burstin HR, O'Neil AC, Orav EJ, Brennan TA. Patient noncompliance with medical advice after the emergency department visit. Ann Emerg Med. 1996;27(1):49-55.
25. Wang NE, Gisondi MA, Golzari M, van der Vlugt TM, Tuuli M. Socioeconomic disparities are negatively associated with pediatric emergency department aftercare compliance. Acad Emerg Med. 2003;10(11):1278-1284.
26. Gardner TL, Dovey SM, Tilyard MW, Gurr E. Differences between prescribed and dispensed medications. NZ Med J. 1996;109(1017):69-72.
27. Kirking MH, Kirking DM. Evaluation of unclaimed prescriptions in an ambulatory care pharmacy. Hosp Pharm. 1993;28(2):181-196
28. Schafheutle EI, Hassell K, Seston EM, Noyce PR. Non-dispensing of NHS prescriptions in community pharmacies. Int J Pharm Pract. 2002;10:11-15.
29. Kinnaird D, Cox T, Wilson JP. Unclaimed prescriptions in a clinic with computerized prescriber order entry. Am J Health Syst Pharm. 2003;60(14):1468-1470.
30. Kirking MH, Zaleon CR, Kirking DM. Unclaimed prescriptions at a university hospital's ambulatory care pharmacy. Am J Health Syst Pharm. 1995;52(5);490-495.
31. Kirking DM, Lee JA, Ellis JJ, Briesacher B, McKercher PL. Patient-reported underuse of prescription medications: a comparison of nine surveys. Med Care Res Rev. 2006;63(4):427-446.
32. Kennedy J, Tuleu I, Mackay K. Unfilled prescriptions of Medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm. 2008;14(6):553-560.
33. Esposito D, Schone E, Williams T, et al. Prevalence of un-claimed prescriptions at military pharmacies. J Manag Care Pharm. 2008;14(6):541-552.
34. Mann DM, Allegrante JP, Natarajan S, Halm EA, Charlson M. Predictors of adherence to statins for primary prevention. Cardio-vasc Drugs Ther. 2007;21(4):311-316.
35. Bronstein JM, Santer L, Johnson V. The use of Medicaid claims as a supplementary source of information on quality of asthma care. J Healthc Qual. 2000;22(6):13-18.
36. Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26(5):1408-1412.
37. Chambers CV, Markson L, Diamond JJ, Lasch L, Berger M. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med. 1999;93(2):88-94.
38. Nair KV, Wolfe P, Valuck RJ, McCollum MM, Ganther JM, Lewis SJ. Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease. J Manag Care Pharm. 2003;9(2):123-133.
39. Shrank WH, Hoang T, Ettner SL, et al. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med. 2006;166(3):332-337.
40. Goldman DP, Joyce GF, Karaca-Mandic P. Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy. Am J Manag Care. 2006;12(1):21-28.
41. Taira DA, Wong KS, Frech-Tamas F, Chung RS. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care. Am J Manag Care. 2006;12(11):678-683.
42. Brixner DI, Joish VN, Oderda GM, Avey SG, Hanson DM, Cannon HE. Effects of benefit design change across 5 disease states. Am J Manag Care. 2007;13(6 pt 2):370-376.
43. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11(11):730-740.
44. Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22(6):864-871.